Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration

Muscle damage elicits a sterile immune response that facilitates complete regeneration. Here, we used mass spectrometry-based lipidomics to map the mediator lipidome during the transition from inflammation to resolution and regeneration in skeletal muscle injury. We observed temporal regulation of glycerophospholipids and production of pro-inflammatory lipid mediators (for example, leukotrienes and prostaglandins) and specialized pro-resolving lipid mediators (for example, resolvins and lipoxins) that were modulated by ibuprofen. These time-dependent profiles were recapitulated in sorted neutrophils and Ly6Chi and Ly6Clo muscle-infiltrating macrophages, with a distinct pro-resolving signature observed in Ly6Clo macrophages. RNA sequencing of macrophages stimulated with resolvin D2 showed similarities to transcriptional changes found during the temporal transition from Ly6Chi macrophage to Ly6Clo macrophage. In vivo, resolvin D2 increased Ly6Clo macrophages and functional improvement of the regenerating muscle. These results reveal dynamic lipid mediator signatures of innate immune cells and provide a proof of concept for their exploitable effector roles in muscle regeneration.

Errataetall:

ErratumIn: Nat Immunol. 2019 Jun;20(6):765-767. - PMID 31048759

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:20

Enthalten in:

Nature immunology - 20(2019), 5 vom: 01. Mai, Seite 626-636

Sprache:

Englisch

Beteiligte Personen:

Giannakis, Nikolas [VerfasserIn]
Sansbury, Brian E [VerfasserIn]
Patsalos, Andreas [VerfasserIn]
Hays, Tristan T [VerfasserIn]
Riley, Colin O [VerfasserIn]
Han, Xianlin [VerfasserIn]
Spite, Matthew [VerfasserIn]
Nagy, Laszlo [VerfasserIn]

Links:

Volltext

Themen:

25167-62-8
Docosahexaenoic Acids
Inflammation Mediators
Journal Article
Lipids
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Resolvin D2

Anmerkungen:

Date Completed 29.04.2019

Date Revised 16.04.2022

published: Print-Electronic

ErratumIn: Nat Immunol. 2019 Jun;20(6):765-767. - PMID 31048759

Citation Status MEDLINE

doi:

10.1038/s41590-019-0356-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM295584734